Micromet, Inc. (NASDAQ: MITI), a transatlantic biotechnology company focused on the development of antibody-based pharmaceutical products for the treatment of cancer, autoimmune and inflammatory diseases, will host a conference call and live webcast on Wednesday, August 9, 2006, at 10:00am Eastern Time (04:00pm Central European Summer Time) to discuss the company's financial results for the second quarter ended June 30, 2006.
